Alumis (ALMS) Market Capitalization (2024 - 2026)
Alumis' (ALMS) quarterly Market Capitalization came in at $3.5 billion in Q2 2026, up 1424.69% year-over-year from $229.7 million in Q2 2025, and up 262.12% quarter-over-quarter from $967.1 million in Q4 2025.
Analysis
Alumis (ALMS) Market Capitalization (2024 - 2026) Analysis & Trends
Alumis (ALMS) has reported Market Capitalization for 3 consecutive years, with $3.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Market Capitalization rose 1424.69% year-over-year to $3.5 billion in Q2 2026; TTM through Jun 2026 was $3.5 billion, a 1424.69% increase from a year earlier, with the FY2025 full-year figure at $967.1 million, up 330.5% from the prior year.
- Market Capitalization was $3.5 billion for Q2 2026 at Alumis, up from $967.1 million in the prior quarter.
- Over five years, Market Capitalization peaked at $3.5 billion in Q2 2026 and troughed at $132.0 million in Q2 2024.
- A 3-year average of $779.7 million and a median of $338.8 million in 2025 frame the typical range for Market Capitalization.
- Across the five-year window, Market Capitalization declined 23.12% in 2025 and soared 1424.69% in 2026, its largest moves.
- Over 3 years, Market Capitalization stood at $224.6 million in 2024, then soared by 330.5% to $967.1 million in 2025, then surged by 262.12% to $3.5 billion in 2026.
- The last three Market Capitalization figures came in at $3.5 billion (Q2 2026), $967.1 million (Q4 2025), and $387.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | Alumis | 966.94 Mn | 464.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.50 Bn |
| Dec 31, 2025 | 967.06 Mn |
| Sep 30, 2025 | 387.73 Mn |
| Jun 30, 2025 | 229.68 Mn |
| Mar 31, 2025 | 289.95 Mn |
| Dec 31, 2024 | 224.64 Mn |
| Sep 30, 2024 | 504.33 Mn |
| Jun 30, 2024 | 132.02 Mn |